A hematologist/oncologist outlines the key unmet needs and challenges in the treatment of patients with relapsed/refractory multiple myeloma.
Case: A 60-Year-Old Woman with Later Relapsed/Refractory Multiple Myeloma
Clinical Presentation:
Prior Treatments:
Follow up and Clinical Workup at Relapse:
Video content above is prompted by the following questions:
Expert Insights on Important Updates in Multiple Myeloma With Marc Braunstein, MD, PhD
August 14th 2024In an interview, Marc Braunstein, MD, PhD, reviewed key updates in multiple myeloma for chimeric antigen receptor (CAR) T-cell and bispecific antibody therapy, and discussed planning for transition of care.
Read More